School of Integrative Biological & Chemical Sciences Faculty Publications and Presentations
Document Type
Article
Publication Date
5-26-2025
Abstract
In this review, we discuss how mutations in glioma are associated with prognosis and treatment efficacy. A fascinating characteristic of glioma and all cancers is that while common growth and developmental pathways are altered, the characteristic mutations are distinct depending on the specific type of tumor with concomitant prognoses. Next-generation sequencing, precision medicine, and artificial intelligence are boosting the employment of molecular biomarkers in cancer diagnosis and treatment. Understanding the biological underpinnings of distinct mutations on critical signaling pathways is crucial for developing novel therapies for glioma.
Recommended Citation
Rajakaruna, Punsasi, Stella Rios, Hana Elnahas, Ashley Villanueva, David Uribe, Sophia Leslie, Walaa A. Abbas, Larissa Barroso, Stephanie Oyervides, Michael Persans, and et al. 2025. "Molecular Biomarkers of Glioma" Biomedicines 13, no. 6: 1298. https://doi.org/10.3390/biomedicines13061298
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publication Title
Biomedicines
DOI
10.3390/biomedicines13061298
Comments
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).